Lithuania vs Türkiye: Communicable diseases — Communicable disease incidence
Communicable diseases — Communicable disease incidence over time
- Lithuania
- Türkiye
How they compare
Türkiye currently reports 132 Cases against 21 Cases in Lithuania, a difference of 111 Cases.
That makes Türkiye's figure about 6.3 times Lithuania's.
Across all 20 years both countries report, Türkiye has been ahead every year.
Lithuania ranks 5th and Türkiye ranks 3rd of 7 countries.
Türkiye has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Lithuania | Türkiye | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 31.2 Cases | 42.8 Cases | 11.6 Cases | Türkiye |
| 2010s | 36.8 Cases | 101.5 Cases | 64.7 Cases | Türkiye |
| 2020s | 28.8 Cases | 84.4 Cases | 55.6 Cases | Türkiye |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher communicable diseases — communicable disease incidence, Lithuania or Türkiye?
- Türkiye, at 132 Cases against 21 Cases in Lithuania as of 2024.
- What is the difference in communicable diseases — communicable disease incidence between Lithuania and Türkiye?
- 111 Cases, with Türkiye ahead.
- How many years of comparable data are there for Lithuania and Türkiye?
- 20 years are reported by both, from 2005 to 2024.
- How do Lithuania and Türkiye rank globally for communicable diseases — communicable disease incidence?
- Lithuania ranks 5th and Türkiye ranks 3rd of 7 countries.
- Where does this data come from?
- Organisation for Economic Co-operation and Development, published as Communicable diseases — Communicable disease incidence. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
This dataset presents time series on Acquired Immunodeficiency Syndrome (AIDS), for the number of AIDS cases and incidence rates per 100 000 population at year of diagnosis. It also includes data on incidence of pertussis, measles, and hepatitis B, in terms of rates of reported cases per 100 000 population. Please refer to the Sources and Methods for detailed country-specific information.